1. Market Research
  2. > Healthcare Market Trends
  3. > Global IV Iron Drugs Market Report: 2014 Edition

Global IV Iron Drugs Market Report: 2014 Edition

  • June 2014
  • -
  • Koncept Analytics
  • -
  • 62 pages

Iron is one of the most important nutritional requirements of the human body as it plays an important role in managing many vital biological processes. These biological processes encompass synthesis of heme which forms the basis of hemoglobin; the oxygen-carrying protein of the blood; the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function apart from others. An individual suffering from iron deficiency can maintain the requisite level of iron mainly through two types of supplements: oral iron supplements and intravenous iron supplements (IV). Treatment with oral iron supplements is simple, inexpensive and a relatively effective way of treating iron deficiency conditions; however, in many iron deficient conditions, oral iron is a less than the ideal treatment.

Intravenous (IV) treatment, in a broad sense, covers all the types of medications delivered intravenously, i.e. directly into the vein, through intravenous drip. Compared to the other routes of infusing medications, the intravenous route is the fastest way to deliver fluids and medications throughout the body. Also, this method ensures 100% bioavailability, which means that the chemicals delivered are fully absorbed by the body. The first iron product for intravenous use was high-molecular-weight iron dextran. Some of the major areas of IV iron application include gynecology, gastroenterology, oncology and surgeries. Hemoglobin, Ferritin, Transferrin, and Hepcidin are major molecules which are critical in the function and regulation of iron.

The key factors driving growth of the global IV iron industry include escalating number of dialysis and hypertension cases, ameliorating economic conditions, increasing global healthcare expenditures, and rising medicines expenditures. Some of the noteworthy trends and developments of this industry encompass novel product development, bundled payment systems and increasing penetration of genecology sector. However, the growth of this industrial sector is being hindered by stringent regulatory structures and adverse affects associated with the use of IV iron products.

The report analyzes the global iron products industry along with an extensive coverage of global and the US IV iron market. The global IV iron market witnesses intense competition with numerous top notch players; such as Galenica Pharmaceuticals, Actavis Inc, AMAG Pharmaceuticals; operating in the marketplace along with small budding players. As a part of analysis of fierce competition prevailing in the industry, product contention has been presented in the report. The company profiles of leading aforementioned players in the market are also incorporated in the report.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table Of Contents

Global IV Iron Drugs Market Report: 2014 Edition
1. Iron in Human Body: An Overview

1.1 IV Iron Application Areas

1.1.1 IV Iron Application in Nephrology

1.2 Iron Deficiency - Anemia

1.2.2 Iron Deficiency Metrics

1.3 IV Iron Therapies for Anemia Treatment

2. Market Analysis

2.1 Global Iron Products Market
-Market Value
-Market Segments

2.1.1 Global IV Iron Market
-Market Value

2.2 The US IV Iron Market
-Market Value
-Non-Dialysis IV Iron Market

3. Market Dynamics

3.1 Growth Drivers

3.1.1 Improved Quality of Treatment outside Dialysis
3.1.2 Increasing Global Healthcare Expenditure
3.1.3 Shift from Rural to Urban Regions
3.1.4 Accelerating Aging Population
3.1.5 Increase in Number of Dialysis Cases
3.1.6 Growing Number of People Suffering from Hypertension
3.1.7 Improving Economic Conditions
3.1.8 Increasing Life Expectancy Rate
3.1.9 Increasing Coverage of Health Insurances
3.1.10 Rising Medicines Expenditures

3.2 Trends and Developments

3.2.1 Novel Product Development
3.2.2 Bundled Payment System
3.2.3 Increasing Penetration in Gynecology Sector

3.3 Challenges

3.3.1 Strict Regulatory Structures
3.3.2 Associated Adverse Effects with IV Iron Products

4. Competitive Landscape

4.1 The US

4.1.1 The US Non- Dialysis IV Iron Market

4.2 Product Contention

5. Company Profiles

5.1 Galenica Pharmaceuticals

5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
-Expansion into New Areas of Pharma Segment
-Focus on Broadening Partnerships

5.2 Actavis Inc.

5.2.1 Business Description
5.2.2 Financial Overview
5.2.3 Business Strategies
-Focus on Strategic Acquisitions and Partnerships
-Expansion of Generic Product Line

5.3 AMAG Pharmaceuticals

5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
-Portfolio Expansion
-Ceaseless Research and Development

6. Market Outlook

6.1 Market Forecast

6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
List of Charts

Global Iron Products Market (2009-2013)
Global Iron Products Market Share - by Segments (2013)
Global Iron Products Value - by Segments (2013)
Global IV Iron Market (2009-2013)
The US IV Iron Market Size (2009-2013)
US Non-Dialysis IV Iron Market (2011-2013)
IV Iron - Avoidance of ESA Initiation in Pre Dialysis Patients
Global Health Care Expenditure Per Capita (2007-2012)
The US Healthcare Expenditure per Capita (2007-2012)
Global Urban Population (2007-2012)
The US Urban Population (2007-2012)
Global Aging Population (Over 65) as a Percentage of Total Population (2008-2012)
The US Aging Population (2008-2012)
Global Dialysis Patient Population
Dialysis Patient Population Share by Region (2012)
Worldwide Patients with End Stage Renal Disease (2005-2013)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
Global GDP (2007-2012)
World Gross National Income (2008-2012)
Global Life Expectancy Rate (2007-2012)
The US Life Expectancy Rate (2007-2013E)
Global Insurance Density (2004-2013)
Global Spending on Medicines (2006-2016E)
Global Spending on Medicine Share by Region (2006-2016E)
The US Spending on Medicine (2007-2016E)
Japan's Spending on Medicine (2007-2016E)
Long and Short Term Concerns about IV Iron
IV Iron Market Share in the US (2013E)
Non-Dialysis IV Iron Market in the US - by Volume (Q114)
Galenica's Revenue Share by Business Segments (2012)
Galenica's Net Sales and Net Profit (2009-2013)
Actavis' Revenue Share by Business Segment (2013)
Actavis' Revenues and Net Income (2009-2013)
AMAG Pharmaceuticals' Revenues (2009-2013)
Global IV Iron Market Forecast (2009-2018F)

List of Tables

Risk Factors for CKD
FDA Approved IV Iron Products
SFP Clinical Trials
IV Iron Products - Safety Profile
IV Iron Administration Comparison
Dependent and Independent Variables (2007-2013)
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Medicated Feed Additives Market by Product, Livestock, Mixture Type, Category, and Region - Global Forecast to 2022

Medicated Feed Additives Market by Product, Livestock, Mixture Type, Category, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

“Global medicated feed additives market projected to grow at a CAGR of 5.41%” The global medicated feed additives market is projected to reach a value of USD 15.32 billion by 2022, growing at a CAGR ...

Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2016

Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2016" provides ...

Global Nutrition and Vitamin Partnering 2010 to 2017

Global Nutrition and Vitamin Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the nutrition and vitamin partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Nutrition and Vitamin ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.